Cozaar 12.5mg tablets

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)

Veiklioji medžiaga:

Losartan potassium

Prieinama:

CST Pharma Ltd

ATC kodas:

C09CA01

INN (Tarptautinis Pavadinimas):

Losartan potassium

Dozė:

12.5mg

Vaisto forma:

Oral tablet

Vartojimo būdas:

Oral

Klasė:

No Controlled Drug Status

Recepto tipas:

Valid as a prescribable product

Produkto santrauka:

BNF: 02050502; GTIN: 5055946803821

Pakuotės lapelis

PATIENT INFORMATION LEAFLET
COZAAR® 12.5MG FILM-COATED TABLETS
(Losartan potassium)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING
THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor,
pharmacist, or nurse.
•
This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their
signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor,
pharmacist, or nurse. This includes any possible side
effects not listed in this leaflet. See section 4.
Your medicine is also available in the following strengths
25mg, 50mg and 100mg Tablets.
WHAT IS IN THIS LEAFLET
1. What Cozaar is and what it is used for
2. What you need to know before you take Cozaar
3. How to take Cozaar
4. Possible side effects
5. How to store Cozaar
6. Contents of the pack and other information
1. WHAT COZAAR IS AND WHAT IT IS USED FOR
Losartan (Cozaar) belongs to a group of medicines known
as angiotensin-II receptor antagonists. Angiotensin-II is a
substance produced in the body which binds to receptors in
blood vessels, causing them to tighten. This results in an
increase in blood pressure. Losartan prevents the binding
of angiotensin-II to these receptors, causing the blood
vessels to relax which in turn lowers the blood pressure.
Losartan slows the decrease of kidney function in patients
with high blood pressure and type 2 diabetes.
Cozaar is used
•
to treat patients with high blood pressure (hypertension)
in adults and in children and adolescents 6-18 years of
age.
•
to protect the kidney in hypertensive type 2 diabetic
patients with laboratory evidence of impaired renal
function and proteinuria ≥ 0.5 g per day (a condition in
which urine contains an abnormal amount of protein).
•
to treat patients with chronic heart failure when therapy
with specific medicines called
angiotensin-converting-enzyme inhibitors (ACE
inhibitors, medicine use